low imatinib trough levels
Showing 1 - 25 of >10,000
Effect of Pharmacogenetics on Imatinib Plasma Level and Response
Active, not recruiting
- Chronic Myeloid Leukemia
- PCR
- HPLC-UV
-
Assiut, EgyptSouth Egypt Cancer Institute
Aug 6, 2022
Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Trial in Worldwide (Imatinib, Nilotinib, Bosutinib)
Recruiting
- Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
- Imatinib
- +4 more
-
Longmont, Colorado
- +128 more
Aug 1, 2022
Atopic Dermatitis, Atopic Dermatitis Eczema Trial in Rotterdam (Dupilumab)
Not yet recruiting
- Atopic Dermatitis
- Atopic Dermatitis Eczema
-
Rotterdam, Zuid-Holland, NetherlandsErasmus Medical Center
Aug 22, 2023
Non Small Cell Lung Cancer Trial in Maastricht, Amsterdam (Cobicistat)
Completed
- Non Small Cell Lung Cancer
-
Maastricht, Limburg, Netherlands
- +1 more
Sep 23, 2022
Metabolic Syndrome, Protection Against Trial in Padang (Nutritionally balanced low-calorie diet)
Completed
- Metabolic Syndrome, Protection Against
- Nutritionally balanced low-calorie diet
-
Padang, Sumatera Barat, IndonesiaUniversitas Andalas
Jan 31, 2023
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)
Recruiting
- Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Imatinib
- +3 more
-
Frankfurt, GermanyDepartment of Medicine, Hematology and Oncology, Goethe Universi
Sep 24, 2023
Gastrointestinal Stromal Tumors Trial in Lexington (Imatinib)
Not yet recruiting
- Gastrointestinal Stromal Tumors
-
Lexington, KentuckyMarkey Cancer Center
Aug 5, 2022
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Minimal Residual Disease Trial in United States (drug, other,
Recruiting
- Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Minimal Residual Disease
- Dasatinib
- +4 more
-
Goodyear, Arizona
- +237 more
Jan 3, 2023
sCD62L and SPARC in Chronic Myeloid Leukemia Patients During
Completed
- Chronic Myeloid Leukemia
- ELISA kit
-
Tanta, EgyptTanta University
May 18, 2022
Severe Hemophilia A Without Inhibitor Trial in Pathum Wan (Extended half-life FVIII concentrates with PK-guided dosing, standard
Completed
- Severe Hemophilia A Without Inhibitor
- Extended half-life FVIII concentrates with PK-guided dosing
- standard half-life FVIII concentrates with weight-based dosing
-
Pathum Wan, Bangkok, ThailandPediatric department, Faculty of medicine, Chulalongkorn Univers
Jul 19, 2022
Dose Adjustment of Enoxaparin in ICU Patients Trial in Kfar Saba (Dose adjustment of Enoxaparin in patients with sub-therapuetic
Completed
- Dose Adjustment of Enoxaparin in ICU Patients
- Dose adjustment of Enoxaparin in patients with sub-therapuetic (prophylactic) levels of factor 10a
-
Kfar Saba, IsraelMeir Medical Center
Jan 23, 2022
Chronic Myelogenous Leukemia Trial in Canada, United States (Nilotinib)
Completed
- Chronic Myelogenous Leukemia
-
Fayetteville, Arkansas
- +22 more
Jun 29, 2021
Psoriasis Trial in Ghent (biological, procedure, other)
Completed
- Psoriasis
- Dose tapering of adalimumab in patients with supratheurapeutic serum trough levels
- +4 more
-
Ghent, BelgiumUniversity Hospital
Jan 5, 2023
Chronic Kidney Diseases, Heart Transplant Trial in Maywood (Conversion from IR Tacrolimus to XR Tacrolimus)
Recruiting
- Chronic Kidney Diseases
- Heart Transplant
- Conversion from IR Tacrolimus to XR Tacrolimus
-
Maywood, IllinoisLoyola University Medical Center
Apr 12, 2022
Renal Transplant Trial in Chapel Hill (Tacrolimus)
Completed
- Renal Transplant
-
Chapel Hill, North CarolinaUniveristy of North Carolina
Jul 18, 2022
Localized Prostate Carcinoma, Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 Trial in United States (Apalutamide,
Recruiting
- Localized Prostate Carcinoma
- +8 more
- Apalutamide
- Quality-of-Life Assessment
-
Tucson, Arizona
- +4 more
Jun 28, 2022
Gastrointestinal Stromal Tumors Trial in Seoul (Paclitaxel)
Recruiting
- Gastrointestinal Stromal Tumors
-
Seoul, Korea, Republic ofAsan Medical Center
Dec 30, 2022
Irritable Bowel Disease Trial in Cairo (Infliximab, Adalimumab)
Recruiting
- Irritable Bowel Disease
-
Cairo, EgyptTropical Medicine department, Ain Shams University Hospitals.
Mar 12, 2022
CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)
Recruiting
- CML
- +3 more
- Asciminib add-on
- +3 more
-
Augusta, Georgia
- +46 more
Jan 23, 2023
Safety of Voriconazole in Critically Ill Elderly Patients
Recruiting
- Invasive Fungal Infection
- other antifungal agents,breathing machine
-
Zhengzhou, Henan, ChinaZhengzhou Central Hospital affiliated to Zhengzhou University
Nov 16, 2023
Kidney Transplant Rejection, Kidney Transplant; Complications Trial in Singapore (Tacrolimus)
Recruiting
- Kidney Transplant Rejection
- Kidney Transplant; Complications
-
Singapore, SingaporeSingapore General Hospital
Dec 5, 2021
Gastrointestinal Stromal Tumor, Major Gastrectomy Trial in Nijmegen (cola)
Terminated
- Gastrointestinal Stromal Tumor
- Major Gastrectomy
- cola
-
Nijmegen, NetherlandsRadboudumc
Dec 4, 2020
Clinical Research of Drug Holiday Based on MRD Detection in GIST
Recruiting
- Gastrointestinal Stromal Tumors
-
Beijing, Beijing, ChinaPeking University People's Hospital
May 11, 2023